Cocrystal Pharma annual operating margin
2011
2019
2020
Cocrystal Pharma's operating margin was −475.97% for fiscal 2020.
View full Cocrystal Pharma company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2020 | 2020-12-31 | −475.97% | +261.48 pp |
| 2019 | 2019-12-31 | −737.45% | −706.87 pp |
| 2011 | 2011-12-31 | −30.58% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −3,032.38% | −2409.64 pp |
| Q1 2026 | 2026-03-31 | −1,047.11% | −621.73 pp |
| Q4 2020 | 2020-12-31 | −287.45% | +11634.19 pp |
| Q3 2020 | 2020-09-30 | −553.99% | −186.51 pp |
| Q2 2020 | 2020-06-30 | −622.74% | −360.92 pp |
| Q1 2020 | 2020-03-31 | −425.38% | −482.04 pp |
| Q4 2019 | 2019-12-31 | −11,921.64% | +3036.69 pp |
| Q3 2019 | 2019-09-30 | −367.48% | +13769.56 pp |
| Q2 2019 | 2019-06-30 | −261.82% | +7767.81 pp |
| Q1 2019 | 2019-03-31 | 56.66% | — |
| Q3 2015 | 2015-09-30 | −14,958.33% | — |
| Q2 2015 | 2015-06-30 | −14,137.04% | — |
| Q1 2015 | 2015-03-31 | −8,029.63% | — |
Across the available reported history, Cocrystal Pharma's operating margin increased from −737.45% to −475.97%, a change of +261.48 percentage points. The latest reported quarter, Q2 2026, shows −3,032.38%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Cocrystal Pharma filings at SEC.gov ↗